Jilin Province Huinan Changlong Bio-pharmacy Company Limited (HKG:8049)
Hong Kong
· Delayed Price · Currency is HKD 2.490
+0.040 (1.63%)
Apr 29, 2026, 2:38 PM HKT
HKG:8049 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 198.88 | 184.25 | 148.21 | 193.57 | 143.28 | Upgrade
|
| Depreciation & Amortization | 28.34 | 27.14 | 27.56 | 33.6 | 28.88 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.37 | 0.06 | 0.06 | 15.59 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.04 | -0.46 | 5.74 | - | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | -5.79 | -5.34 | -5.43 | -4.52 | -3.4 | Upgrade
|
| Provision & Write-off of Bad Debts | -8.56 | 29.72 | 0.72 | 5.99 | -1.52 | Upgrade
|
| Other Operating Activities | -8.86 | -67.35 | -13.29 | -57.88 | 13.16 | Upgrade
|
| Change in Accounts Receivable | 41.18 | -41.43 | 22.65 | -51.45 | 14.56 | Upgrade
|
| Change in Inventory | -24.26 | 42.13 | 20.41 | -51.71 | -13.94 | Upgrade
|
| Change in Accounts Payable | -1.59 | -7.04 | 4.9 | 14.35 | 5.2 | Upgrade
|
| Change in Unearned Revenue | 6.53 | 5.91 | -8.61 | 8.73 | 7.66 | Upgrade
|
| Change in Other Net Operating Assets | 83.71 | 52.06 | 113.02 | 97.73 | 21.21 | Upgrade
|
| Operating Cash Flow | 313.24 | 219.65 | 315.95 | 203.99 | 215.09 | Upgrade
|
| Operating Cash Flow Growth | 42.61% | -30.48% | 54.88% | -5.16% | 42.23% | Upgrade
|
| Capital Expenditures | -12.45 | -11.02 | -31.84 | -11.32 | -92.84 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.07 | 0.3 | 0.02 | - | 12.45 | Upgrade
|
| Cash Acquisitions | - | - | - | - | 0.8 | Upgrade
|
| Investment in Securities | -219.94 | -304.39 | 134.89 | -112.02 | -90.04 | Upgrade
|
| Other Investing Activities | 3.14 | 4.18 | 5.97 | 5.37 | 9.01 | Upgrade
|
| Investing Cash Flow | -229.19 | -310.93 | 109.04 | -117.97 | -160.61 | Upgrade
|
| Long-Term Debt Issued | - | - | 80 | - | - | Upgrade
|
| Long-Term Debt Repaid | -72 | -8 | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -72 | -8 | 80 | - | - | Upgrade
|
| Other Financing Activities | 13.8 | 17.94 | 17.22 | 0.5 | 1.16 | Upgrade
|
| Financing Cash Flow | -176.8 | -25.01 | -186.45 | -27.71 | -25.2 | Upgrade
|
| Net Cash Flow | -92.75 | -116.29 | 238.54 | 58.31 | 29.28 | Upgrade
|
| Free Cash Flow | 300.8 | 208.63 | 284.11 | 192.68 | 122.26 | Upgrade
|
| Free Cash Flow Growth | 44.18% | -26.57% | 47.45% | 57.60% | 133.03% | Upgrade
|
| Free Cash Flow Margin | 33.35% | 23.68% | 33.76% | 22.89% | 17.33% | Upgrade
|
| Free Cash Flow Per Share | 0.54 | 0.37 | 0.51 | 0.34 | 0.22 | Upgrade
|
| Cash Interest Paid | 1.39 | 2.03 | 0.52 | 0.47 | 0.34 | Upgrade
|
| Cash Income Tax Paid | 44.96 | 42.61 | 60.47 | 37.29 | 24.72 | Upgrade
|
| Levered Free Cash Flow | 284.83 | 229.25 | 273.09 | 135.48 | 114.8 | Upgrade
|
| Unlevered Free Cash Flow | 285.69 | 230.52 | 273.41 | 135.77 | 115.02 | Upgrade
|
| Change in Working Capital | 105.57 | 51.63 | 152.36 | 17.65 | 34.68 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.